宫颈癌是我国最常见的女性生殖系统恶性肿瘤。对于宫颈早期浸润癌，临床病理因素不仅是提示预后的重要线索，也是术后补充治疗的重要依据。淋巴脉管间隙浸润被认为是宫颈癌复发的中危因素之一，有研究报道淋巴脉管间隙浸润与淋巴结转移和深层间质浸润有关。目前对有淋巴脉管浸润的早期宫颈癌的治疗仍是以手术为主的综合治疗，术后根据相关危险因素制定患者的辅助治疗方案。机器人手术在早期宫颈癌治疗中广泛应用，尽管有研究表明微创手术可能与宫颈癌预后不良有关，且可能增加淋巴脉管浸润的发生率，但尚无研究表明机器人手术对淋巴脉管间隙浸润有明确影响。

Cervical cancer is the most common malignant tumor that occurs in female reproductive system in China. Clinicopathological factors for early cervical cancer are very important to prognosis and postoperative decision-making. Lymphovascular space invasion is considered as one of the moderate risk factors to recurrence of cervical cancer. It is reported that lymphovascular space invasion maybe caused by lymph node metastasis and deep stromal invasion. At present, the standard treatment of early cervical cancer with lymphatic-vascular invasion is a comprehensive treatment based on radical hysterectomy,and postoperative treatment plan is made for patients in consideration of adverse pathologic factors. Robotic surgery has been widely used in the treatment of early cervical cancer. However, some studies indicated that minimally invasive surgery might be associated with poor prognosis of cervical cancer, and minimally invasive surgery might increase the incidence of lymphovascular space invasion. In spite of that, there’s no evidence that significant influence of robotic surgery on lymphovascular space invasion exists.

收稿日期：2021-11-13 录用日期：2022-03-07

Received Date: 2021-11-13 Accepted Date: 2022-03-07

基金项目：重庆市自然科学基金（cstc2021jcyj-msxmX0120）

Foundation Item: The Natural Science Foundation of Chongqing (cstc2021jcyj-msxmX0120)

通讯作者：肖琳，Email：xiaolin@hospital.cqmu.edu.cn

Corresponding Author: XIAO Lin，Email: xiaolin@hospital.cqmu.edu.cn

引用格式：张好，王蓉，陈万丽，等. 机器人手术对早期宫颈癌淋巴脉管间隙浸润影响的研究进展[J]. 机器人外科学杂志（中英文），2022，3（4）：329-336.

Citation: ZHANG H，WANG R，CHEN W L，et al. Research progress on the influence of robotic surgery on lymphovascular space invasion in early cervical cancer[J]. Chinese Journal of Robotic Surgery，2022，3(4): 329-336.

[1] Sung H, Ferlay J, Siegel R L, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J].CA Cancer J Clin, 2021, 71(3): 209-249.

[2] Bhatla N, Aoki D, Sharma D N, et al. Cancer of the cervix uteri [J]. Int J Gynaecol Obstet, 2018, 143(Suppl2): 22-36.

[3] dos Reis R, Burzawa J K, Tsunoda A T, et al.Lymphovascular space invasion portends poor prognosis in low-risk endometrial cancer [J]. Int J Gynecol Cancer,2015, 25(7): 1292-1299.

[4] Peters B S, Armijo P R, Krause C, et al. Review of emerging surgical robotic technology [J]. Surg Endosc,2018, 32(4): 1636-1655.

[5] Memarzadeh S, Natarajan S, Dandade D P, et al.Lymphovascular and perineural invasion in the parametria: a prognostic factor for early-stage cervical cancer [J]. Obstet Gynecol, 2003, 102(3): 612-619.

[6] Wenzel H H B, van Kol K G G, Nijman H W, et al.Cervical cancer with≤5 mm depth of invasion and >7 mm horizontal spread-Is lymph node assessment only required in patients with LVSI? [J]. Gynecol Oncol,2020, 158(2): 282-286.

[7] Yanaranop M, Sathapornteera N, Nakrangsee S. Risk factors of pelvic lymph node metastasis in cervical adenocarcinoma following radical hysterectomy and pelvic lymphadenectomy [J]. J Med Assoc Thai, 2014,97(Suppl 11): S87-95.

[8] Silva-Filho A L, Traiman P, Triginelli S A, et al. Association between CD31 expression and histopathologic features in stage IB squamous cell carcinoma of the cervix [J]. Int J Gynecol Cancer, 2006, 16(2):757-762.

[9] Milam M R, Frumovitz M, dos Reis R, et al. Preoperative lymph-vascular space invasion is associated with nodal metastases in women with early-stage cervical cancer [J].Gynecol Oncol, 2007, 106(1): 12-15.

[10] Murakami I, Fujii T, Kameyama K, et al. Tumor volume and lymphovascular space invasion as a prognostic factor in early invasive adenocarcinoma of the cervix [J]. J Gynecol Oncol, 2012, 23(3): 153-158.

[11] ZHANG Y, YAN M, HE J, et al. Significant effects of lymph and blood vascular invasion on the prognosis of early-stage cervical squamous cell carcinoma [J]. J Obstet Gynaecol Res, 2010, 36(5): 1015-1022.

[12] YAN W, QIU S, DING Y, et al. Prognostic value of lymphovascular space invasion in patients with early stage cervical cancer in Jilin, China: a retrospective study [J]. Medicine (Baltimore), 2019, 98(40): e17301.

[13] ZHU J, CAO L, WEN H, et al. The clinical and prognostic implication of deep stromal invasion in cervical cancer patients undergoing radical hysterectomy [J]. J Cancer, 2020, 11(24): 7368-7377.

[14] YANG L, JIA X, LI N, et al. Comprehensive clinicpathological characteristics of cervical cancer in southwestern China and the clinical significance of histological type and lymph node metastases in young patients [J]. PLoS One, 2013, 8(10): e75849.

[15] Taarnhoj G A, Christensen I J, Lajer H, et al. Risk of recurrence, prognosis, and follow-up for Danish women with cervical cancer in 2005-2013: a national cohort study [J]. Cancer, 2018, 124(5): 943-951.

[16] Weyl A, Illac C, Lusque A, et al. Prognostic value of lymphovascular space invasion in early-stage cervical cancer [J]. Int J Gynecol Cancer, 2020, 30(10): 1493-1499.

[17] Creasman W T, Kohler M F. Is lymph vascular space involvement an independent prognostic factor in early cervical cancer? [J]. Gynecol Oncol, 2004, 92(2):525-529.

[18] Takekuma M, Kasamatsu Y, Kado N, et al. The issues regarding postoperative adjuvant therapy and prognostic risk factors for patients with stage Ⅰ-Ⅱ cervical cancer: a review [J]. J Obstet Gynaecol Res, 2017, 43(4): 617-626.

[19] Sedlis A, Bundy B N, Rotman M Z, et al. A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage Ⅰ B carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a gynecologic oncology group study

[J]. Gynecol Oncol, 1999, 73(2): 177-183. 

[20] Rotman M, Sedlis A, Piedmonte M R, et al. A phase Ⅲ randomized trial of postoperative pelvic irradiation in stage Ⅰ B cervical carcinoma with poor prognostic features: follow-up of a gynecologic oncology group study [J]. Int J Radiat Oncol Biol Phys, 2006, 65(1):

169-176.

[21] LI M, HU M, WANG Y, et al. Adjuvant chemoradiotherapy versus radiotherapy in cervical cancer patients with intermediate-risk factors: a systematic review and meta-analysis [J]. Eur J Obstet Gynecol Reprod Biol, 2019. DOI: 10.1016/j.ejogrb.2019.04.039.

[22] Nitecki R, Ramirez P T, Frumovitz M, et al. Survival after minimally invasive vs open radical hysterectomy for early-stage cervical cancer: a systematic review and meta-analysis [J]. JAMA Oncol, 2020, 6(7): 1019-1027.

[23] Gala R B, Margulies R, Steinberg A, et al. Systematic review of robotic surgery in gynecology: robotic techniques compared with laparoscopy and laparotomy [J]. J Minim Invasive Gynecol, 2014, 21(3): 353-361.

[24] Fanning J, Fenton B, Purohit M. Robotic radical hysterectomy [J]. Am J Obstet Gynecol, 2008, 198(6):649e1-4.

[25] Shazly S A, Murad M H, Dowdy S C, et al. Robotic radical hysterectomy in early stage cervical cancer: a systematic review and meta-analysis [J]. Gynecol Oncol,2015, 138(2): 457-471.

[26] Gallotta V, Conte C, D’Indinosante M, et al. Robotic surgery in elderly and very elderly gynecologic cancer patients [J]. J Minim Invasive Gynecol, 2018, 25(5):872-877.

[27] Gallotta V, Conte C, Federico A, et al. Robotic versus laparoscopic radical hysterectomy in early cervical cancer: a case matched control study [J]. Eur J Surg Oncol, 2018, 44(6): 754-759.

[28] Lee E J, Kang H, Kim D H. A comparative study of laparoscopic radical hysterectomy with radical abdominal hysterectomy for early-stage cervical cancer: a long-term follow-up study [J]. Eur J Obstet Gynecol Reprod Biol, 2011, 156(1): 83-86.

[29] Malzoni M, Tinelli R, Cosentino F, et al. Total laparoscopic radical hysterectomy versus abdominal radical hysterectomy with lymphadenectomy in patients with early cervical cancer: our experience [J]. Ann Surg Oncol, 2009, 16(5): 1316-1323.

[30] Nam J H, Park J Y, Kim D Y, et al. Laparoscopic versus open radical hysterectomy in early-stage cervical cancer: long-term survival outcomes in a matched cohort study [J]. Ann Oncol, 2012, 23(4): 903-911.

[31] Sert B M, Boggess J F, Ahmad S, et al. Robot-assisted versus open radical hysterectomy: a multi-institutional experience for early-stage cervical cancer [J]. Eur J Surg Oncol, 2016, 42(4): 513-522.

[32] Shah C A, Beck T, Liao J B, et al. Surgical and oncologic outcomes after robotic radical hysterectomy as compared to open radical hysterectomy in the treatment of early cervical cancer [J]. J Gynecol Oncol, 2017,28(6): e82.

[33] Soliman P T, Frumovitz M, Sun C C, et al. Radical hysterectomy: a comparison of surgical approaches after adoption of robotic surgery in gynecologic oncology [J].Gynecol Oncol, 2011, 123(2): 333-336.

[34] Ramirez P T, Frumovitz M, Pareja R, et al. Minimally invasive versus abdominal radical hysterectomy for cervical cancer [J]. N Engl J Med, 2018, 379(20): 1895-1904.

[35] Cusimano M C, Baxter N N, Gien L T, et al. Impact of surgical approach on oncologic outcomes in women undergoing radical hysterectomy for cervical cancer [J].Am J Obstet Gynecol, 2019, 221(6): 619e1-e24.

[36] Doo D W, Kirkland C T, Griswold L H, et al.Comparative outcomes between robotic and abdominal radical hysterectomy for Ⅰ B1 cervical cancer: results from a single high volume institution [J]. Gynecol Oncol,2019, 153(2): 242-247.

[37] Kim S I, Cho J H, Seol A, et al. Comparison of survival outcomes between minimally invasive surgery and conventional open surgery for radical hysterectomy as primary treatment in patients with stage ⅠB1 - ⅡA2 cervical cancer [J]. Gynecol Oncol, 2019, 153(1): 3-12.

[38] Melamed A, Margul D J, Chen L, et al. Survival after minimally invasive radical hysterectomy for early-stage cervical cancer [J]. N Engl J Med, 2018, 379(20): 1905-1914.

[39] Paik E S, Lim M C, Kim M H, et al. Comparison of laparoscopic and abdominal radical hysterectomy in early stage cervical cancer patients without adjuvant treatment: Ancillary analysis of a Korean Gynecologic Oncology Group Study (KGOG 1028) [J]. Gynecol Oncol, 2019, 154(3): 547-553.

[40] Uppal S, Gehrig P A, Peng K, et al. Recurrence rates in patients with cervical cancer treated with abdominal versus minimally invasive radical hysterectomy: a multiinstitutional retrospective review study [J]. J Clin Oncol,2020, 38(10): 1030-1040.

[41] Tewari K S. Minimally invasive surgery for earlystage cervical carcinoma: interpreting the laparoscopic approach to cervical cancer trial results [J]. J Clin Oncol, 2019, 37(33): 3075-3080.

[42] Kitahara S, Walsh C, Frumovitz M, et al. Vascular pseudoinvasion in laparoscopic hysterectomy specimens for endometrial carcinoma: a grossing artifact? [J]. Am J Surg Pathol, 2009, 33(2): 298-303.

[43] Krizova A, Clarke B A, Bernardini M Q, et al. Histologic artifacts in abdominal, vaginal, laparoscopic, and robotic hysterectomy specimens: a blinded, retrospective review [J]. Am J Surg Pathol, 2011, 35(1): 115-126.

[44] Logani S, Herdman A V, Little J V, et al. Vascular“pseudo invasion” in laparoscopic hysterectomy specimens: a diagnostic pitfall [J]. Am J Surg Pathol,2008, 32(4): 560-565.

[45] Folkins A K, Nevadunsky N S, Saleemuddin A, et al.Evaluation of vascular space involvement in endometrial

adenocarcinomas: laparoscopic vs abdominal hysterectomies [J]. Mod Pathol, 2010, 23(8): 1073-1079.

[46] Frimer M, Khoury-Collado F, Murray M P, et al.Micrometastasis of endometrial cancer to sentinel lymph nodes: is it an artifact of uterine manipulation? [J].Gynecol Oncol, 2010, 119(3): 496-499.

[47] Rakowski J A, Tran T A, Ahmad S, et al. Does a uterine manipulator affect cervical cancer pathology or identification of lymphovascular space involvement? [J].Gynecol Oncol, 2012, 127(1): 98-101.

[48] LIU Y, HUANG S, MING X, et al. Surgical approach and use of uterine manipulator are not associated with lvsi in surgery for early-stage cervical cancer [J]. J Minim Invasive Gynecol, 2021, 28(9): 1573-1578.

[49] 李津津, 欧阳熙坪, 龚雪, 等. 机器人辅助腹腔镜与传统腹腔镜宫颈癌手术的临床对比研究[J]. 机器人外科学杂志（中英文）, 2020, 1(3): 166-173.

[50] Kanao H, Matsuo K, Aoki Y, et al. Feasibility and outcome of total laparoscopic radical hysterectomy with no-look no-touch technique for FIGO ⅠB1 cervical cancer [J]. J Gynecol Oncol, 2019, 30(3): e71.

[51] 付振华, 张智, 杨蕾, 等. 早期子宫颈癌行机器人手术系统免举宫器联合经阴道封闭肿瘤广泛性子宫切除术20 例分析[J]. 中国实用妇科与产科杂志,

2020, 36(9): 683-685.